The rational design and evaluation of a peptide inhibitor of the PD-1/PD-L1 interaction

被引：0
|
作者：
Boohaker, Rebecca J. [1 ]
Sambandam, Vijaya [1 ]
Suto, Mark [1 ]
Xu, Bo [1 ]
机构：
[1] Southern Res Inst, Birmingham, AL 35255 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5668
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer ImmunotherapyY
    Yin, Huawu
    Zhou, Xiuman
    Huang, Yen-Hua
    King, Gordon J.
    Collins, Brett M.
    Gao, Yanfeng
    Craik, David J.
    Wang, Conan K.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (44) : 18536 - 18547
  • [2] Rational design of a potent macrocyclic peptide inhibitor targeting the PD-1/PD-L1 protein-protein interaction
    Miao, Qi
    Zhang, Wanheng
    Zhang, Kuojun
    Li, He
    Zhu, Jidong
    Jiang, Sheng
    RSC ADVANCES, 2021, 11 (38) : 23270 - 23279
  • [3] Rational design of a potent macrocyclic peptide inhibitor targeting the PD-1/PD-L1 protein-protein interaction
    Zhu, Jidong (zhujd@sioc.ac.cn), 1600, Royal Society of Chemistry (11):
  • [4] Rational design and development of a peptide inhibitor for the PD-1/PD-Ll interaction
    Boohaker, Rebecca J.
    Sambandam, Vijaya
    Segura, Isaac
    Miller, James
    Suto, Mark
    Xu, Bo
    CANCER LETTERS, 2018, 434 : 11 - 21
  • [5] Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction
    Hayward, Deanne
    Goddard, Zoe R.
    Cominetti, Marco M. D.
    Searcey, Mark
    Beekman, Andrew M.
    CHEMICAL COMMUNICATIONS, 2024, 60 (63) : 8228 - 8231
  • [6] Rational Design of Multivalent Anticancer Peptides Inhibiting PD-1/PD-L1 Interaction
    Zhang, Bailing
    Cheng, Xiyao
    Gao, Meng
    Huang, Yongqi
    Su, Zhengding
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 297A - 297A
  • [7] Design and evaluation of α-helix-based peptide inhibitors for blocking PD-1/PD-L1 interaction
    Rui, Mengjie
    Zhang, Wen
    Mi, Ke
    Ni, Hairong
    Ji, Wei
    Yu, Xuefei
    Qin, Jiangjiang
    Feng, Chunlai
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 253
  • [8] Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint
    Magiera-Mularz, Katarzyna
    Kuska, Katarzyna
    Skalniak, Lukasz
    Grudnik, Przemyslaw
    Musielak, Bogdan
    Plewka, Jacek
    Kocik, Justyna
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Sala, Dominik
    Wladyka, Benedykt
    Siedlar, Maciej
    Holak, Tad A.
    Dubin, Grzegorz
    ADVANCED THERAPEUTICS, 2021, 4 (02)
  • [9] Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy
    Wenjie Zhai
    Xiuman Zhou
    Mingxia Zhai
    Wanqiong Li
    Yunhui Ran
    Yixuan Sun
    Jiangfeng Du
    Wenshan Zhao
    Lingxiao Xing
    Yuanming Qi
    Yanfeng Gao
    Science China(Life Sciences), 2021, 64 (04) : 548 - 562
  • [10] Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy
    Zhai, Wenjie
    Zhou, Xiuman
    Zhai, Mingxia
    Li, Wanqiong
    Ran, Yunhui
    Sun, Yixuan
    Du, Jiangfeng
    Zhao, Wenshan
    Xing, Lingxiao
    Qi, Yuanming
    Gao, Yanfeng
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 548 - 562
12345